whatsup, in terms of comparison with other bios we've been well and truly left behind in a hot sector where many of the bio specs have tripled or more in value. Yet over the last 6-12 month period Patrys have kicked plenty of goals, but the market doesn't seem to see the value. Not yet anyhow. Their time will come - it will have to be something that really wows the market - ie a licencing deal. The market wants a sniff of money/revenue imo before they pile in.
pab research summary #1 , page-33
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 5414724 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1558945 | 5 |
View Market Depth
| Last trade - 15.55pm 17/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable